Robert Stevenson
Internal Medicine · New Castle, INNPI 1740376805
Payments from drug & device makers
Across 514 payments — averaging $18.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- AbbVie$1K
- Novo Nordisk$1K
- Lilly USA, LLC$797
- Pfizer$459
- GSK$438
- plus $3K from 39 others
What the payments were for
- Food & beverage$9,293100%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$726
- AIRSUPRA$563
- BREZTRI$338
- ELIQUIS$217
- FASENRA$133
- AMVUTTRA$125
- Ozempic$123
- RYBELSUS$122
- AREXVY$121
- ArmonAir Digihaler$117
- ProAir Digihaler$117
- AirDuo RespiClick$117
- Wegovy$116
How this compares
$9,302 in reported general payments places this provider in the 90th percentile of 1,747 internal medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| HetliozTasimelteon | 15 | $335,707 |
| JardianceEmpagliflozin | 166 | $215,499 |
| OzempicSemaglutide | 98 | $112,064 |
| MounjaroTirzepatide | 55 | $72,438 |
| JanuviaSitagliptin Phosphate | 57 | $70,023 |
| EliquisApixaban | 69 | $67,225 |
| FarxigaDapagliflozin Propanediol | 35 | $41,454 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 211 | $33,769 |
| TrulicityDulaglutide | 14 | $20,574 |
| LinzessLinaclotide | 21 | $20,525 |
| CaplytaLumateperone Tosylate | 12 | $19,620 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 66 | $18,499 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 27 | $17,994 |
| XareltoRivaroxaban | 12 | $17,719 |
| Breo ElliptaFluticasone/Vilanterol | 39 | $17,528 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Vanda Pharmaceuticals Inc.Hetlioz | $16 | $335,70715 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $340 | $224,984180 claims |
| Novo NordiskOzempic | $1,311 | $112,06498 claims |
| Lilly USA, LLCMounjaro, Trulicity | $797 | $93,01169 claims |
| MerckJanuvia | $30 | $70,02357 claims |
| PfizerEliquis | $459 | $67,22569 claims |
| AstraZenecaFarxiga | $1,691 | $41,45435 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $438 | $35,52166 claims |
| AbbVieLinzess | $1,432 | $20,52521 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $292 | $19,62012 claims |
| Johnson & JohnsonXarelto | $88 | $17,71912 claims |
| Sanofi-aventis U.S. LLCLantus | $26 | $4,89816 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,747 internal medicine providers in Indiana.
Other internal medicine in New Castle
- Robert BuynakValparaiso$24.2M
- Mohammed AllawNewburgh$3.6M
- Raj VuppalanchiIndianapolis$3.4M
- Phillip TothIndianapolis$3.2M
- George CornettFranklin$1.3M
- Ajita NarayanLafayette$951K
- Abhinav SinghGreenwood$738K
- Georgiann LinnemeierIndianapolis$692K
- Wa'el BakdashAnderson$625K
- Rita SchmidSouth Bend$599K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.